NATHAN MILLER: Open Payments
NPI 1073672473 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 54 payments from 15 companies in 2025. Trend: 2023 $1,372 · 2024 $1,551 · 2025 $1,806
Food & beverage: $1,806
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $493 |
| Medtronic, Inc. | 13 | $477 |
| Saluda Medical Americas, Inc. | 6 | $217 |
| SPR Therapeutics, Inc | 6 | $106 |
| Averitas Pharma Inc. | 4 | $105 |
| BIOTRONIK NRO, Inc. | 1 | $101 |
| Bioventus LLC | 1 | $71 |
| Abbott Laboratories | 3 | $60 |
| Nalu Medical, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $35 |
Products named: SYNCHROMEDII, WaveWriter Alpha Prime 16, Evoke, SPRINT PNS System, QUTENZA, Prospera, Intracept, DUROLANE.
Industry payments across CA — which companies pay providers there.
